cancer news

Using smokeless tobacco raises your risk of oral cancer by 80 percent and your risk of esophageal and pancreatic cancer by 60 percent, according to researchers who concluded that encouraging smokers to switch to smokeless products is bad public-health policy.

A scientific study published here Wednesday sheds light on why men who eat a lot of broccoli are less likely to develop prostate cancer.

WEDNESDAY, July 2 (HealthDay News) -- Smokeless tobacco products (STPs), which include products such as snuff and chew tobacco, do increase the user's risk of cancer -- just not as much as smoking doe...

0 posts More than half of all people with chronic pain are smokers, and research at suggests that cigarette smoking may make chronically painful conditions worse. In a recent study published in the Jo...

Diets high in saturated fat may increase the risk of prostate cancer progression, researchers from the University of Texas M. D. Anderson Cancer Center in Houston report.

A British woman is pregnant with a baby that does not carry the hereditary breast cancer gene.

Cancer clinicians should understand and consider the economic impact of new interventions when considering cancer treatment, which often have substantial costs, according to a report appearing in the July/August issue of CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society. The report says health care budget constraints have made it necessary for clinicians to be aware of the relative costs and benefits of new interventions used in cancer screening, diagnosis, treatment, and support services for patients.read more

With the incidence of skin cancer annually on the rise, the American Pharmacists Association (APhA) encourages consumers to talk to their pharmacist about sunburn prevention, sunburn treatment and medications that increase the skin's sensitivity to the sun. Besides being medication experts, pharmacists are also knowledgeable about how to prevent and treat common summertime ailments, such as sunburns.

By measuring the activity of four genes in cancer cells, scientists at the Albert Einstein College of Medicine of Yeshiva University accurately predicted whether colorectal tumors are sensitive or resistant to 5-Fluorouracil (5-FU), an important chemotherapy drug.

Each day, a staggering number of cells perform a feat that still amazes researchers with its complexity: they divide to produce perfect replicas of each other. The process is called mitosis, and an inability to control it is one of the hallmarks of cancer.